This finding suggests that the increased glycolytic capacity and the occurrence of lactylation are primary contributors to elevated CEACAM6 levels, serving as a key factor in conferring and transmitting resistance to 5-FU in CRC. This evidence concerns the gene CEACAM6 and colorectal carcinoma.